• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  03/23/2012
Trade Name:  QNASL
Generic Name or Proper Name (*):  beclomethasone dipropionate
Indications Studied:  Treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis
Label Changes Summary:  "Safety and effectiveness in children 12 years and older have been established "Safety and effectiveness in <12 years have not been established "Corticosteroids may cause a reduction in growth velocity when administered to pediatric patients. Routinely monitor the growth of pediatric patients receiving QNASL Nasal Aerosol "The potential for QNASL Nasal Aerosol to cause reduction in growth velocity in susceptible patients or when given at higher than recommended dosages cannot be ruled out "Information on safety, adverse events and clinical trials "New dosage form
Product Labeling:  Labeling  Opens a new window
Sponsor:  Teva
Therapeutic Category:  Anti-inflammatory, topical